Carnegie Investment Counsel’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $37.5M | Buy |
182,001
+18,381
| +11% | +$4.08M | 0.73% | 36 |
|
|
2025
Q4 | $37.4M | Buy |
163,620
+24,426
| +18% | +$5.56M | 0.69% | 37 |
|
|
2025
Q3 | $32.2M | Buy |
139,194
+25,146
| +22% | +$5.12M | 0.61% | 45 |
|
|
2025
Q2 | $21.2M | Sell |
114,048
-2,168
| -2% | -$403K | 0.43% | 69 |
|
|
2025
Q1 | $23.3M | Buy |
116,216
+72,193
| +164% | +$14M | 0.55% | 49 |
|
|
2024
Q4 | $7.82M | Buy |
44,023
+5,592
| +15% | +$1.03M | 0.22% | 116 |
|
|
2024
Q3 | $7.59M | Buy |
38,431
+1,252
| +3% | +$234K | 0.22% | 111 |
|
|
2024
Q2 | $6.38M | Sell |
37,179
-739
| -2% | -$122K | 0.2% | 114 |
|
|
2024
Q1 | $6.9M | Sell |
37,918
-600
| -2% | -$103K | 0.21% | 115 |
|
|
2023
Q4 | $5.97M | Sell |
38,518
-21
| -0.1% | -$3.06K | 0.2% | 121 |
|
|
2023
Q3 | $5.74M | Buy |
38,539
+363
| +1% | +$53.3K | 0.22% | 114 |
|
|
2023
Q2 | $5.14M | Sell |
38,176
-2,807
| -7% | -$412K | 0.19% | 129 |
|
|
2023
Q1 | $6.53M | Buy |
40,983
+1,332
| +3% | +$204K | 0.26% | 103 |
|
|
2022
Q4 | $6.41M | Buy |
39,651
+1,096
| +3% | +$168K | 0.28% | 103 |
|
|
2022
Q3 | $5.17M | Buy |
38,555
+8,812
| +30% | +$1.26M | 0.25% | 109 |
|
|
2022
Q2 | $4.55M | Buy |
29,743
+1,445
| +5% | +$221K | 0.21% | 121 |
|
|
2022
Q1 | $4.59M | Sell |
28,298
-1,280
| -4% | -$186K | 0.17% | 142 |
|
|
2021
Q4 | $4M | Buy |
29,578
+12,654
| +75% | +$1.49M | 0.13% | 155 |
|
|
2021
Q3 | $1.82M | Buy |
16,924
+542
| +3% | +$61.9K | 0.07% | 189 |
|
|
2021
Q2 | $1.84M | Buy |
16,382
+866
| +6% | +$97.5K | 0.07% | 196 |
|
|
2021
Q1 | $1.67M | Buy |
15,516
+961
| +7% | +$103K | 0.07% | 197 |
|
|
2020
Q4 | $1.56M | Sell |
14,555
-244
| -2% | -$23.4K | 0.07% | 194 |
|
|
2020
Q3 | $1.3M | Buy |
14,799
+465
| +3% | +$43.8K | 0.07% | 195 |
|
|
2020
Q2 | $1.41M | Buy |
14,334
+616
| +4% | +$54.2K | 0.08% | 184 |
|
|
2020
Q1 | $1.04M | Sell |
13,718
-39
| -0.3% | -$3.32K | 0.07% | 193 |
|
|
2019
Q4 | $1.22M | Buy |
13,757
+5,205
| +61% | +$432K | 0.07% | 206 |
|
|
2019
Q3 | $648K | Sell |
8,552
-5,493
| -39% | -$377K | 0.04% | 256 |
|
|
2019
Q2 | $1.02M | Sell |
14,045
-665
| -5% | -$52.3K | 0.07% | 212 |
|
|
2019
Q1 | $1.19M | Sell |
14,710
-69,131
| -82% | -$5.66M | 0.08% | 202 |
|
|
2018
Q4 | $7.73M | Sell |
83,841
-16,740
| -17% | -$1.47M | 0.72% | 37 |
|
|
2018
Q3 | $9.2M | Buy |
100,581
+2,497
| +3% | +$237K | 0.75% | 34 |
|
|
2018
Q2 | $9.41M | Sell |
98,084
-35,690
| -27% | -$3.49M | 0.72% | 43 |
|
|
2018
Q1 | $13.9M | Sell |
133,774
-11,431
| -8% | -$1.26M | 1.17% | 22 |
|
|
2017
Q4 | $16.5M | Buy |
145,205
+2,752
| +2% | +$259K | 1.46% | 10 |
|
|
2017
Q3 | $13.5M | Sell |
142,453
-5,700
| -4% | -$434K | 1.58% | 10 |
|
|
2017
Q2 | $10.5M | Buy |
148,153
+9,211
| +7% | +$619K | 1.27% | 18 |
|
|
2017
Q1 | $9.17M | Sell |
138,942
-926
| -0.7% | -$58.2K | 1.14% | 23 |
|
|
2016
Q4 | $8.91M | Buy |
139,868
+1,080
| +0.8% | +$65.9K | 1.19% | 20 |
|
|
2016
Q3 | $8.35M | Buy |
138,788
+1,706
| +1% | +$110K | 1.2% | 16 |
|
|
2016
Q2 | $8.89M | Buy |
137,082
+10,245
| +8% | +$624K | 1.25% | 14 |
|
|
2016
Q1 | $7.24M | Buy |
126,837
+3,304
| +3% | +$184K | 1.11% | 23 |
|
|
2015
Q4 | $6.81M | Buy |
123,533
+942
| +0.8% | +$54.3K | 1.18% | 25 |
|
|
2015
Q3 | $6.43M | Sell |
122,591
-21,835
| -15% | -$1.42M | 1.1% | 25 |
|
|
2015
Q2 | $9.7M | Buy |
144,426
+4,726
| +3% | +$309K | 1.7% | 5 |
|
|
2015
Q1 | $8.62M | Buy |
139,700
+81,612
| +140% | +$4.93M | 1.49% | 8 |
|
|
2014
Q4 | $3.92M | Buy |
58,088
+4,270
| +8% | +$269K | 0.74% | 50 |
|
|
2014
Q3 | $3.11M | Buy |
53,818
+21,105
| +65% | +$1.17M | 0.62% | 59 |
|
|
2014
Q2 | $1.85M | Buy |
32,713
+2,933
| +10% | +$154K | 0.42% | 80 |
|
|
2014
Q1 | $1.53M | Buy |
29,780
+408
| +1% | +$20.6K | 0.4% | 77 |
|
|
2013
Q4 | $1.55M | Buy |
29,372
+13,613
| +86% | +$669K | 0.42% | 78 |
|
|
2013
Q3 | $705K | Buy |
15,759
+6,396
| +68% | +$284K | 0.22% | 107 |
|
|
2013
Q2 | $387K | Buy |
+9,363
| New | +$409K | 0.13% | 145 |
|
Other funds holding ABBV
VCM
VPM
Carnegie Investment Counsel's ABBV Position: Q1 2026 in Review
Carnegie Investment Counsel increased its AbbVie (ABBV) stake by 11% in Q1 2026, buying an estimated $4.08M and bringing the position to 182,001 shares worth $37.5M. The position accounts for 0.73% of the portfolio, ranked #36.
Carnegie Investment Counsel first reported a position in ABBV in Q2 2013 and has held it in 52 quarters since. 4,077 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- Carnegie Investment Counsel held 182,001 shares of AbbVie worth $37.5M as of Q1 2026.
- Carnegie Investment Counsel bought 18,381 AbbVie shares in Q1 2026, an estimated $4.08M.
- AbbVie made up 0.73% of Carnegie Investment Counsel's portfolio in Q1 2026, its #36 holding.
- Carnegie Investment Counsel first reported a position in AbbVie in Q2 2013 and has held it in 52 quarters since.
- 4,077 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on Carnegie Investment Counsel's 13F filing for Q1 2026, filed 1 May 2026.